React, Adapt, Evolve: Clinical Trials During and Beyond COVID-19
Our white paper explores TrialSpark’s core areas of focus during the COVID-19 pandemic.
Ensuring continuity of clinical research during COVID-19
Within each focus area below, we offer specific solutions implemented in response to COVID-19 and flag proactive steps to improve efficiency and flexibility in future protocols.
Patient Drug Supply